Last updated on June 2020

A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for IMISC


Brief description of study

TARGET-DERM is a 5-year, longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.

Clinical Study Identifier: NCT03661866

Find a site near you

Start Over

Forest Hills Dermatology Group

Forest Hills, NY United States
2.91miles
  Connect »

Ichan School of Medicine

New York, NY United States
8.68miles
  Connect »

Advanced Allergy & Asthma, PLLC

Rockville Centre, NY United States
9.68miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.